Isthmus Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Isthmus Partners's DGX Position: Q2 2025 in Review
Isthmus Partners sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 89,874 shares — an estimated $15.2M sold.
Isthmus Partners first reported a position in DGX in Q4 2014 and held it in 16 quarters. The position peaked at $15.2M in Q1 2025. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.
- Isthmus Partners reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
- Isthmus Partners sold 89,874 Quest Diagnostics shares in Q2 2025, an estimated $15.2M.
- Isthmus Partners first reported a position in Quest Diagnostics in Q4 2014 and held it in 16 quarters.
- Isthmus Partners's Quest Diagnostics position peaked at $15.2M in Q1 2025.
- 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.
Based on Isthmus Partners's 13F filing for Q2 2025, filed 13 Aug 2025.